Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Equity Ratio (2016 - 2025)

Historic Equity Ratio for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to 0.1.

  • ProPhase Labs' Equity Ratio fell 7485.4% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 7485.4%. This contributed to the annual value of 0.12 for FY2024, which is 7834.23% down from last year.
  • As of Q3 2025, ProPhase Labs' Equity Ratio stood at 0.1, which was down 7485.4% from 0.27 recorded in Q2 2025.
  • In the past 5 years, ProPhase Labs' Equity Ratio ranged from a high of 0.73 in Q4 2022 and a low of 0.1 during Q3 2025
  • For the 5-year period, ProPhase Labs' Equity Ratio averaged around 0.52, with its median value being 0.62 (2021).
  • In the last 5 years, ProPhase Labs' Equity Ratio skyrocketed by 9533.38% in 2021 and then crashed by 7834.23% in 2024.
  • Quarter analysis of 5 years shows ProPhase Labs' Equity Ratio stood at 0.66 in 2021, then grew by 10.57% to 0.73 in 2022, then decreased by 26.0% to 0.54 in 2023, then tumbled by 78.34% to 0.12 in 2024, then dropped by 10.24% to 0.1 in 2025.
  • Its Equity Ratio was 0.1 in Q3 2025, compared to 0.27 in Q2 2025 and 0.3 in Q1 2025.